Saxagliptin
- 1 lab
- Human trial2
Outcomes
1First-phase insulin secretion
upin humans1
1 study
First-phase insulin secretion
upin humans1
Saxagliptin increases first-phase insulin secretion in humans (p < 0.05).
“In treatment-specific analyses, MET, SAXA and PIO increased first-phase ISecr at 2 years (p < 0.05).”
Human trialprediabetes2 yearsn = 15
ADA Scientific Sessions 2026 abstract5 Jun 2026
Latest
1 in 12 monthsADA Scientific Sessions 2026 Abstract
Long-Term Impact of Early Oral Antidiabetic Therapy on Insulin Secretion Phases in Individuals with Prediabetes (PreDM): Insights from Hyperglycemic Clamp Studies
Non-randomised trial in 60 peoplePrediabetes
ADA Scientific Sessions 2025 Abstract
Beta-Cell Preservation with Early Oral Antidiabetic Medications in Prediabetes (PreDM)
Randomised trial in 154 peoplePrediabetes